Fig. 3From: Does ALK-rearrangement predict favorable response to the therapy of bevacizumab plus pemetrexed in advanced non-small-cell lung cancer? Case report and literature reviewImaging examination confirmed the disease progression after two cycle inducing chemotherapy. a, c The primary lesion on the lower left lobe was larger than before. b, d New metastasis in the right upper lobe was foundBack to article page